BENITIONSClinical Trial Intelligence

Diabetes Disparities: Texting to Extend Treatment (DD-TXT)

Не применимо Завершено NCT04227379

ЗаболеваниеDiabetes Mellitus, Type 2
ФазаНе применимо
СпонсорVA Office of Research and Development
СтатусЗавершено
Участники366 участн.
ВмешательствоIntervention 1- DSMS+, Comparison - DSMS
Дата начала30.01.2023
Дата завершения30.04.2025
Публикация результатов1.06.2026

Кратко

One way to help Veterans improve their diabetes control is through the use of technology to help provide information, motivation, and reminders necessary to support diabetes self-management. The study will seek input from diverse groups of Veterans living with diabetes to help develop a new customizable, interactive texting intervention that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie for Veterans", a VA texting system for self-management support. Patients will be randomized to receive a once-daily standard diabetes self-management texting intervention called DSMS based on standard diabetes self-management education content or a customizable, patient-centered diabetes self-management support intervention with additional features called DSMS Plus (DSMS+) in order to test the comparative effectiveness of these two texting interventions.

Change in HbA1c Percent Time in Control

pre-enrollment, 6 month follow up · percent (%) of time in control

DSMS23.41 ± 34.96 percent (%) of time in control
DSMS+ (DSMS Plus)21.61 ± 40.55 percent (%) of time in control
p-value.6519
Mean Difference (Net)1.80 (95% CI -6.05–9.65)

Change in HbA1c

pre-enrollment, 6 month follow-up · Percentage of glycosylated hemoglobin

DSMS-0.36 ± 1.37 Percentage of glycosylated hemoglobin
DSMS+ (DSMS Plus)-0.40 ± 1.29 Percentage of glycosylated hemoglobin
p-value.7552
Mean Difference (Net).05 (95% CI -.25–.34)

Открыть в BENITIONS Открыть на ClinicalTrials.gov

Другие исследования по этому заболеванию

Все исследования

Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.